Physician profile
Luis Enrique Ortiz
NPI 1982921086
$23,628.72
in general payments reported to CMS, 2019-2025
7 companies · $7,724 in 2025
The $7,724 reported for 2025 was more than what 94% of Sleep Medicine (Pediatrics) providers received nationally (typical 2025 total: $235).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $132 · 2020: $431 · 2022: $16.34 · 2023: $10K · 2024: $5,284 · 2025: $7,724.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $21K · Food and Beverage: $1,312 · Travel and Lodging: $771.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $20,966.25 |
| Food and Beverage | $1,312.08 |
| Travel and Lodging | $771.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Jazz Pharmaceuticals INC. | $9,774.95 | 2020-2023 | Xywav |
| Avadel Cns Pharmaceuticals, LLC | $7,394.22 | 2023-2025 | Lumryz |
| Harmony Biosciences LLC | $6,027.50 | 2024-2025 | |
| Inspire Medical Systems, INC. | $284.13 | 2023-2025 | Inspire |
| Avadel Specialty Pharmaceuticals, LLC | $111.78 | 2019 | |
| Shire North American Group INC | $19.80 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $16.34 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Luis Ortiz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.